MBF Bioscience Wins Prestigious Tibbetts Award in Recognition of Outstanding Technological Innovation

MBF Bioscience received a prestigious Tibbetts Award during a ceremony at the White House on May 16. The Tibbetts Award recognizes MBF Bioscience for a number of accomplishments including: technological innovation, serving federal Research and Development needs, encouraging diverse participation, and increasing the practical commercial use of federal research.

The Tibbetts Award is given to companies who participate in the Small Business Innovation Research program which is run by the U.S. Small Business Administration. The SBIR program is a highly competitive program that encourages small businesses to engage in Federal Research/Research and Development (R/R&D) that has the potential for commercialization.

Jack Glaser receives the Tibbetts Award on behalf of MBF Bioscience. From left to right: Roland Tibbetts (sitting), Karen Mills, SBA Administrator, Jack Glaser, Pravina Raghavan, Director, Innovation and Technology at SBA

Roland Tibbetts, who was instrumental in developing the SBIR program, presented the award to Jack Glaser, President of MBF Bioscience. MBF Bioscience has been an active participant in the SBIR program for many years. It has received numerous SBIR awards that have helped develop many products that bioscience researchers rely on, including Neurolucida, Stereo Investigator, Biolucida, AutoSpine, AutoSynapse, and Virtual Tissue 3D.

From left to right: Margaret Grabb, Ph.D, NIMH SBIR/STTR Coordinator, Sophie Glaser, Roland Tibbetts, Jack Glaser, Cait Glaser

MBF was featured in local Vermont media outlets to talk about winning the Tibbetts Award. Jack Glaser was interviewed on a local VT television news station. You can view the segment on the WCAX website. MBF was also highlighted in the Burlington Free Press.